4.7 Review

The Alter Retina: Alternative Splicing of Retinal Genes in Health and Disease

Journal

Publisher

MDPI
DOI: 10.3390/ijms22041855

Keywords

retina; alternative splicing; inherited retinal dystrophies; splicing factors; non-canonical splice site variants; deep intronic variants; microexons

Funding

  1. APIF grant (Universitat de Barcelona)
  2. CIBER/ISCIII
  3. Ministerio de Ciencia e Innovacion/FEDER [PID2019-108578RB-I00]
  4. Generalitat de Catalunya [2017 SGR 738]

Ask authors/readers for more resources

Alternative splicing of mRNA is crucial for regulating and increasing the diversity of transcriptome and proteome. The retina, as an extension of the central nervous system, illustrates the high diversity of neural transcripts with complex splicing programs. Modulation of alternative splicing in the retina is essential for designing novel therapeutic approaches for retinal dystrophies and enabling precision medicine for specific mutations.
Alternative splicing of mRNA is an essential mechanism to regulate and increase the diversity of the transcriptome and proteome. Alternative splicing frequently occurs in a tissue- or time-specific manner, contributing to differential gene expression between cell types during development. Neural tissues present extremely complex splicing programs and display the highest number of alternative splicing events. As an extension of the central nervous system, the retina constitutes an excellent system to illustrate the high diversity of neural transcripts. The retina expresses retinal specific splicing factors and produces a large number of alternative transcripts, including exclusive tissue-specific exons, which require an exquisite regulation. In fact, a current challenge in the genetic diagnosis of inherited retinal diseases stems from the lack of information regarding alternative splicing of retinal genes, as a considerable percentage of mutations alter splicing or the relative production of alternative transcripts. Modulation of alternative splicing in the retina is also instrumental in the design of novel therapeutic approaches for retinal dystrophies, since it enables precision medicine for specific mutations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available